Aiping Qin

机构：Guangxi Medical University, Jiangsu Vocational College of Medicine, First Affiliated Hospital of GuangXi Medical University, The University of Texas at Austin · ORCID：0000-0003-4625-333X

发表论文 46 篇 · 总被引 1378 次 · h-index 21

代表论文

• Triple‐Targeting Delivery of CRISPR/Cas9 To Reduce the Risk of Cardiovascular Diseases (2019 · Angewandte Chemie International Edition · 被引 142)
• Homotypic Targeting Delivery of siRNA with Artificial Cancer Cells (2020 · Advanced Healthcare Materials · 被引 116)
• The reversion of DNA methylation-induced miRNA silence via biomimetic nanoparticles-mediated gene delivery for efficient lung adenocarcinoma therapy (2022 · Molecular Cancer · 被引 61)
• CuS Nanodot-Loaded Thermosensitive Hydrogel for Anticancer Photothermal Therapy (2018 · Molecular Pharmaceutics · 被引 42)
• Bismuth chelate as a contrast agent for X-ray computed tomography (2020 · Journal of Nanobiotechnology · 被引 39)
• Promoter methylation-regulated miR-148a-3p inhibits lung adenocarcinoma (LUAD) progression by targeting MAP3K9 (2022 · Acta Pharmacologica Sinica · 被引 30)